ICP Parking Lot/Vaccines: Difference between revisions
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
=[[Vaccines/Bibliography|Bibliography]]= | =[[Vaccines/Bibliography|Bibliography]]= | ||
* | * 2009, 35 Am. J. L. and Med. | ||
** [[Vaccines/Bibliography/35 Am. J. L. and Med.|Highlights]] | ** [[Vaccines/Bibliography/35 Am. J. L. and Med.|Highlights]] | ||
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf | * 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf | ||
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf | * Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf | ||
* Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/. | * Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/. | ||
* LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf | |||
=Navigation= | =Navigation= | ||
Back to [[Main Page]] | Back to [[Main Page]] | ||
Back to [[Biotechnology_-_Genomic_and_Proteomics]] | Back to [[Biotechnology_-_Genomic_and_Proteomics]] |
Revision as of 19:56, 5 May 2010
Bibliography
- 2009, 35 Am. J. L. and Med.
- 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
- Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
- Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
- LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf
Back to Main Page Back to Biotechnology_-_Genomic_and_Proteomics